Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Cardiac Surgery
- Hematology
- Nuclear Medicine
- Neurology
- ENT
- Dermatology and Cosmetology
- Cardiovascular Medicine
- Medical Radiography
Abstract
Citation: Ann Clin Case Rep. 2021;6(1):2029.DOI: 10.25107/2474-1655.2029
Type 1 Cryoglobulinemia Secondary to Primary Plasma Cell Leukemia: A Rare Presentation of a Rare Entity
Antonio G Faieta1*, Madhupreet Kaur2 and Tawhida Khatoon2
1Department of Medical Oncology, The James Cancer Center, USA
2Department of Internal Medicine, Beaumont Health, USA
*Correspondance to: Antonio G Faieta
PDF Full Text Case Report | Open Access
Abstract:
Primary Plasma Cell Leukemia (pPCL) is a rare and aggressive form of plasma cell dyscrasia that comprises 1% of plasma cell dyscrasias. It is characterized by the presence of more than 20% plasma cells in the peripheral blood or an absolute peripheral blood plasma cell count of greater than 2.0 x 109 cells/L. Symptoms are similar to Multiple Myeloma (MM) but develop in a shorter period of time. A case of secondary plasma cell leukemia associated with type 1 cryoglobulinemia was reported in the literature. To our knowledge, this is the first case of pPCL with associated necrotizing lesions and cryoglobulin level up to 81%.
Keywords:
Cite the Article:
Faieta AG, Kaur M, Khatoon T. Type 1 Cryoglobulinemia Secondary to Primary Plasma Cell Leukemia: A Rare Presentation of a Rare Entity. Ann Clin Case Rep. 2021; 6: 2029.